Efficacy and safety of a quadrivalent influenza vaccine in children aged 6–35 months: A global, multiseasonal, controlled, randomized Phase III study-Reference-Cited by-同舟云学术

Efficacy and safety of a quadrivalent influenza vaccine in children aged 6–35 months: A global, multiseasonal, controlled, randomized Phase III study

Published:2022-04 Issue:18 Volume:40 Page:2626-2634
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Esposito Susanna,Nauta Jos,Lapini Giulia,Montomoli Emanuele^ORCID,van de Witte Serge

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. Vaccines against influenza WHO position paper – November 2012;World Health Organization;World Health Organization weekly epidemiological record,2012

2. Influenza;Krammer;Nat Rev Dis Primers,2018

3. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults;Greenberg;Vaccine,2013

4. Evolution-informed forecasting of seasonal influenza A (H3N2);Du;Sci Transl Med,2017

5. The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century;Caini;PLoS ONE,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of a clinical study of the influenza tetravalent inactivated subunit adjuvant vaccine Grippol Quadrivalent in children aged 6 months to 5 years (inclusive);Pediatric pharmacology;2024-07-03

2. Influvac Tetra: clinical experience on safety, efficacy, and immunogenicity;Expert Review of Vaccines;2023-12-15

3. In-silico design of novel 2-((4-chloro-6-methoxy-1H-indol-3-yl)thio)-N-(2-ethoxyphenyl)acetamide derivatives as potential inhibitors of influenza neuraminidase protein receptor;Intelligent Pharmacy;2023-12

4. Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2023-08

5. Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea;Infectious Diseases and Therapy;2023-06